SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : momo-T/FIF -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (11474)1/8/2018 8:28:29 PM
From: Biotech Jim  Read Replies (1) | Respond to of 12215
 
Here is a potential standard for NASH fibrosis scores, obtained by GILD with selonsertib, the ASK1 inhibitor discovered by GSK. Published in Hepatology 2017.

onlinelibrary.wiley.com




To: Miljenko Zuanic who wrote (11474)1/18/2018 4:15:29 PM
From: Miljenko Zuanic  Respond to of 12215
 
<So, any progressive positive news will be more than welcome for current investors.>

secfilings.nasdaq.com

Well, someone think that two very promising POC compounds are not sufficient to keep few shares extra few months????


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News